Feasibility of bone marrow stromal cells autologous transplantation for dilated cardiomyopathy

Cheng Zhou , Chenyuan Yang , Shiliang Xiao , Hongwen Fei

Current Medical Science ›› 2007, Vol. 27 ›› Issue (22) : 75 -78.

PDF
Current Medical Science ›› 2007, Vol. 27 ›› Issue (22) : 75 -78. DOI: 10.1007/s11596-007-0122-1
Article

Feasibility of bone marrow stromal cells autologous transplantation for dilated cardiomyopathy

Author information +
History +
PDF

Abstract

The feasibility of bone marrow stromal cells autologous transplantation for rabbit model of dilated cardiomyopathy induced by adriamycin was studied. Twenty rabbits received 2 mg/kg of adriamycin intravenously once a week for 8 weeks (total dose, 16 mg/kg) to induce the cardiomyopathy model with the monitoring of cardiac function by transthoracic echocardiography. Marrow stromal cells were isolated from cell-transplanted group rabbits and were culture-expanded on the 8th week. On the 10th week, cells were labeled with 4,6-diamidino-2-phenylindole (DAPI), and then injected into the myocardium of the same rabbits. The results showed that viable cells labeled with DAPI could be identified in myocardium at 2nd week after transplantation. Histological findings showed the injury of the myocardium around the injection site was relieved with less apoptosis and more expression of bcl-2. The echocardiography found the improvement of local tissue movement from (2.12±0.51) cm/s to (3.81±0.47) cm/s (P<0.05) around the inject site, but no improvement of heart function as whole. It was concluded bone marrow stromal cells transplantation for dilated cardiomyopathy was feasibe. The management of cells in vitro, the quantity and the pattern of the cells transplantation and the action mechanism still need further research.

Keywords

dilated cardiomyopathy / adriamycin / marrow stromal cells / rabbits

Cite this article

Download citation ▾
Cheng Zhou, Chenyuan Yang, Shiliang Xiao, Hongwen Fei. Feasibility of bone marrow stromal cells autologous transplantation for dilated cardiomyopathy. Current Medical Science, 2007, 27(22): 75-78 DOI:10.1007/s11596-007-0122-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Tomita J, Li R K, Richard D. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation, 100(19 Suppl): II 247–256

[2]

AmodaL., McGrathB., CocksM., et al.. Adriamycin cardiomyopathy in the rabbit: an animal model of low cardiac failure with activation of vasoconstriction mechanisms. Cardiovasc Res, 1985, 19: 378-382

[3]

WakitaniS., SaitoT., CaplanA. I.. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 1995, 18: 1417-1426

[4]

LiR. K., MickleD. A. G., WeiselR. D., et al.. The natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation, 1997, 96(SupplII): II 179-187

[5]

TarnowskiB. I., SpinaleF. G., NicholsonJ. H.. DAPI as a useful stain for nuclear quantitation. Biotech Histochem, 1991, 66: 296-302

[6]

WangJ. S., DominiqueS. T.. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg, 2001, 122: 699-705

[7]

OrlicD., KajsturaJ., ChimentiS., et al.. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA, 2001, 98(1): 10 344-10 349

AI Summary AI Mindmap
PDF

75

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/